Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Ophthalmology · Uveitis

The Anatomy and Biology of Your Diagnosis

At a Glance

Autoimmune uveitis is inflammation caused by the immune system in the eye’s middle layer and nearby tissues. Doctors classify it by location—front, middle, back, or all parts of the eye—and rule out infections before using immune-suppressing treatment.

Understanding your diagnosis starts with a map of the eye. Uveitis is not a single disease, but a family of inflammatory conditions named for the uvea, the middle layer of the eye. Because the uvea contains most of the eye’s blood vessels, it is a primary pathway for immune cells to enter [1].

Doctors classify uveitis based on exactly where the inflammation is centered. This classification is vital because it determines which treatments will reach the target and what complications your doctor will monitor for [2].

The Four Anatomical Subtypes

The eye is divided into compartments, and your “type” of uveitis depends on which structures are involved:

  • Anterior Uveitis: This is the most common form. It affects the front of the eye, specifically the iris (the colored part) and the ciliary body (which produces eye fluid) [1][3]. It often causes redness, pain, and sensitivity to light.
  • Intermediate Uveitis: This occurs in the middle of the eye. It involves the vitreous (the jelly-like substance) and the pars plana (a part of the ciliary body) [1]. Patients often see “floaters” or clumps of inflammatory cells called snowballs [4]. When the vitreous is inflamed, it is called vitritis.
  • Posterior Uveitis: This affects the back of the eye, specifically the retina (the light-sensing tissue) and the choroid (the blood-vessel layer beneath it) [1]. This form is often painless but can cause significant vision loss through scarring or swelling.
  • Panuveitis: This term is used when inflammation is present in all parts of the eye—front, middle, and back—simultaneously [5].

The Biology of the Attack

In autoimmune or “noninfectious” uveitis, the immune system targets the eye. Specialized white blood cells called T cells are primary drivers of this process [6].

Specifically, two types of “helper” cells—Th1 and Th17 cells—become overactive. They release inflammatory signals called cytokines (like Interleukin-17 and TNF-alpha), which act like a siren, calling in more immune cells like macrophages [7][8]. These cells can break down the protective blood-retinal barrier, allowing further inflammation to enter [9][10]. Often, the exact trigger for this immune response is unknown (idiopathic).

Evaluating for Infection First

Before your care team can confidently treat your uveitis with immunosuppressants, they must perform a critical “differential diagnosis.” This means they must carefully assess your eye to ensure the inflammation is not caused by an active infection [1].

This step is the most important part of your early care. If a doctor prescribes powerful immune-suppressing drugs (like steroids or biologics) to someone who actually has an infection, the drugs could reduce the body’s ability to fight that infection, allowing it to spread [11]. While no test can prove an infection is absent with 100% certainty, targeted testing makes it highly unlikely.

Common infections that can masquerade as noninfectious uveitis include:

  • Syphilis: Often called “the great imitator,” it can look like almost any form of uveitis [12].
  • Tuberculosis (TB): Can cause chronic inflammation, especially in the back of the eye [13].
  • Herpes Viruses (HSV/VZV/CMV): Often cause sudden, intense inflammation and high eye pressure [14].
  • Toxoplasmosis: A common parasite that can leave scars on the retina [15].

Your doctor will likely order blood work, imaging, or even a small sample of eye fluid based on your symptoms, exposure history, and geography before moving forward with noninfectious treatments [15][16].

Common questions in this guide

How is autoimmune uveitis classified in the eye?
Doctors classify uveitis by the part of the eye with the most inflammation. Anterior uveitis affects the iris and ciliary body, intermediate uveitis affects the vitreous and pars plana, posterior uveitis affects the retina and choroid, and panuveitis involves all three regions.
Why do doctors test for infection before treating autoimmune uveitis?
Infections such as syphilis, tuberculosis, herpes viruses, and toxoplasmosis can look like noninfectious uveitis. Steroids and other immune-suppressing medicines can make an untreated infection spread, so doctors may use blood tests, imaging, or eye-fluid testing before starting them.
What symptoms can different types of uveitis cause?
Anterior uveitis commonly causes redness, eye pain, and sensitivity to light. Intermediate uveitis often causes floaters, while posterior uveitis may be painless but can cause blurred vision or vision loss; panuveitis can combine features.
What do vitritis and snowballs mean in uveitis?
Vitritis means inflammation in the vitreous, the jelly-like substance in the middle of the eye. Snowballs are clumps of inflammatory cells seen in the vitreous and are associated with intermediate uveitis.
Why might someone with uveitis see a rheumatologist?
A rheumatologist can assess whether uveitis is linked to an autoimmune condition affecting other parts of the body. Referral depends on your symptoms, medical history, eye examination, and test results.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which anatomical classification (anterior, intermediate, posterior, or panuveitis) do I have, and how does that affect my treatment plan?
  2. 2.What specific tests were performed to evaluate for infections like syphilis, TB, and herpes before we started my current treatment?
  3. 3.Is my inflammation limited to one eye, or are both eyes involved?
  4. 4.Are there signs of "vitritis" or "snowball" floaters in my vitreous?
  5. 5.Based on my diagnosis, do I need to see a specialist like a rheumatologist to check for a systemic autoimmune disease?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Uveitis in Adults: A Review.

    Maghsoudlou P, Epps SJ, Guly CM, Dick AD

    JAMA 2025; (334(5)):419-434 doi:10.1001/jama.2025.4358.

    PMID: 40434762
  2. 2

    Etiology and Anatomical Location of Uveitis-Prognostic Factors for Disease Course and Laterality.

    Mitkova-Hristova VT, Atanassov MA

    Life (Basel, Switzerland) 2025; (15(6)) doi:10.3390/life15060882.

    PMID: 40566536
  3. 3

    Patterns of uveitis at the Apex Institute for Eye Care in India: Results from a prospectively enrolled patient data base (2011-2013).

    Venkatesh P, Gogia V, Shah B, et al.

    International ophthalmology 2016; (36(3)):365-72 doi:10.1007/s10792-015-0128-9.

    PMID: 26408195
  4. 4

    Association of Fuchs Heterochromic Iridocyclitis with Multiple Sclerosis.

    Brichová M, Lízrová JP, Heissigerová J, et al.

    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2024; (80(4)):188-192 doi:10.31348/2024/17.

    PMID: 38538292
  5. 5

    Immune checkpoint inhibitor-associated uveitis in metastatic melanoma: case report and literature review.

    Akcay P, Esen Baris M, Güven S, et al.

    Melanoma research 2026; (36(4)):314-320 doi:10.1097/CMR.0000000000001112.

    PMID: 42200697
  6. 6

    CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease.

    Chen YH, Lightman S, Calder VL

    International journal of molecular sciences 2021; (22(17)) doi:10.3390/ijms22179584.

    PMID: 34502490
  7. 7

    Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis.

    Zhong Z, Su G, Kijlstra A, Yang P

    Progress in retinal and eye research 2021; (80()):100866 doi:10.1016/j.preteyeres.2020.100866.

    PMID: 32422390
  8. 8

    Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt-Koyanagi-Harada Syndrome.

    Zhu Y, Yu Q, Ma Y, et al.

    Investigative ophthalmology & visual science 2026; (67(6)):4 doi:10.1167/iovs.67.6.4.

    PMID: 42227805
  9. 9

    Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice.

    Meng X, Fang S, Zhang Z, et al.

    Cellular & molecular immunology 2017; (14(8)):702-711 doi:10.1038/cmi.2015.107.

    PMID: 26996065
  10. 10

    Functionally distinct IFN-γ+ IL-17A+ Th cells in experimental autoimmune uveitis: T-cell heterogeneity, migration, and steroid response.

    Chen YH, Eskandarpour M, Gondrand A, et al.

    European journal of immunology 2020; (50(12)):1941-1951 doi:10.1002/eji.202048616.

    PMID: 32652562
  11. 11

    Fulminant proliferative vitreoretinopathy in syphilitic uveitis.

    Queiroz Rde P, Diniz AV, Vasconcelos-Santos DV

    Journal of ophthalmic inflammation and infection 2016; (6(1)):6 doi:10.1186/s12348-016-0075-2.

    PMID: 26920001
  12. 12

    Ocular syphilis: case series (2000-2015) from 2 tertiary care centres in Montreal, Canada.

    Vadboncoeur J, Labbé AC, Fortin C, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2020; (55(1)):30-37 doi:10.1016/j.jcjo.2019.05.009.

    PMID: 31712031
  13. 13

    Current Practices in Ocular Tuberculosis: A Survey of Brazilian Specialists.

    Fernández Zamora Y, Finamor LP, Silva LMP, et al.

    Ocular immunology and inflammation 2020; (28(2)):256-261 doi:10.1080/09273948.2018.1563705.

    PMID: 30806119
  14. 14

    Viral anterior uveitis.

    Babu K, Konana VK, Ganesh SK, et al.

    Indian journal of ophthalmology 2020; (68(9)):1764-1773 doi:10.4103/ijo.IJO_928_20.

    PMID: 32823392
  15. 15

    Low-volume multiplex solid-phase PCR without DNA extraction for etiological diagnosis of infectious uveitis.

    Ferracioli-Oda E, Tanaka T, Gouvea MSG, et al.

    Indian journal of ophthalmology 2026; (74(2)):234-239 doi:10.4103/IJO.IJO_1135_25.

    PMID: 41581039
  16. 16

    Current perspective on infectious uveitis.

    Gupta A

    Indian journal of ophthalmology 2026; (74(6)):798-803 doi:10.4103/IJO.IJO_3289_25.

    PMID: 41669781

This page is for informational purposes only and does not constitute medical advice. Your ophthalmologist and care team should interpret your uveitis type, test results, and treatment needs.

Get notified when new evidence is published on autoimmune uveitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.